against rheumatoid arthritis and atopic dermatitis. AbbVie’s immunology treatments generate approximately 50% of total revenue, oncology products contribute about 30%, neuroscience adds roughly 10%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback